SAIL insider plans 12,961-share sale in notice for SailPoint (NYSE: SAIL)

Rhea-AI Filing Summary

Brian Carolan filed a notice to sell common stock of SAIL. The filing covers a proposed sale of 12,961 shares of common stock through Morgan Stanley Smith Barney LLC on Nasdaq, with an aggregate market value of $257,960.83, at a time when 561,625,760 shares were outstanding. The shares to be sold relate to a larger block of 111,257 shares of common stock acquired on January 5, 2026 via restricted stock unit vesting from the issuer as compensation, with payment on the same date.

Over the prior three months, the same seller reported three sales of SAIL common stock: 36,899 shares on October 8, 2025 for $828,289.38 in gross proceeds, 84,699 shares on October 9, 2025 for $1,899,229.42, and 15,234 shares on January 6, 2026 for $292,963.42. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	12961	257960.83	561625760	01/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common stock	01/05/2026	RSU vesting	Issuer			111257	01/05/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Carolan 11120 Four Points Drive Suite 100 Austin TX 78726	Common Stock	10/08/2025	36899	828289.38
Brian Carolan 11120 Four Points Drive Suite 100 Austin TX 78726	Common Stock	10/09/2025	84699	1899229.42
Brian Carolan 11120 Four Points Drive Suite 100 Austin TX 78726	Common Stock	01/06/2026	15234	292963.42

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction does the SAIL Form 144 disclose?

The filing discloses that Brian Carolan intends to sell 12,961 shares of SAIL common stock through Morgan Stanley Smith Barney LLC on Nasdaq, with an aggregate market value of $257,960.83.

How many SAIL shares were outstanding when this sale was planned?

The notice states that there were 561,625,760 shares of SAIL common stock outstanding at the time the planned sale of 12,961 shares was reported.

How did the seller acquire the SAIL shares referenced in this Form 144?

The seller acquired 111,257 shares of SAIL common stock on January 5, 2026 through restricted stock unit (RSU) vesting from the issuer as compensation, with payment also on January 5, 2026.

What SAIL stock sales has the filer made in the past three months?

Over the past three months, the filer sold SAIL common stock in three transactions: 36,899 shares on October 8, 2025 for $828,289.38, 84,699 shares on October 9, 2025 for $1,899,229.42, and 15,234 shares on January 6, 2026 for $292,963.42 in gross proceeds.

Which broker is handling the planned SAIL share sale in this Form 144?

The planned sale of 12,961 SAIL common shares is to be executed through Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the seller make about SAIL in this notice?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.